Blau Farmaceutica SA (BLAU3)
BOV
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | ||||
Total Assets | 2.44B | 2.5B | 2.51B | 2.5B | 3.07B | 3.05B | 3.16B | 3.1B |
Total Current Assets | 1.71B | 1.68B | 1.63B | 1.42B | 1.63B | 1.55B | 1.62B | 1.5B |
Cash and Equivalents | 9.18M | 14.11M | 23.77M | 97.5M | 30.35M | 31.5M | 26.49M | 20.42M |
Total Non-Current Assets | 1.17B | 1.32B | 1.38B | 1.64B | 2.1B | 2.17B | 2.23B | 2.31B |
Total Liabilities | 682.62M | 681.11M | 671.83M | 630.16M | 1.1B | 1.06B | 1.15B | 1.06B |
Total Current Liabilities | 421.38M | 371.11M | 346.51M | 343.3M | 472.4M | 335.93M | 424.6M | 376.32M |
Total Non-Current Liabilities | 461.25M | 510M | 525.32M | 436.86M | 1.06B | 1.22B | 1.22B | 1.14B |
Common Equity | 1.32B | 1.32B | 1.32B | 1.32B | 1.32B | 1.32B | 1.32B | 1.32B |
Retained Earnings | 268.39M | 0 | 51.95M | 56.98M | 156.38M | 0 | 40.09M | 88.82M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 738.44M | 1.27B | 2.33B | 2.5B | 3.05B |
Total Current Assets | 501.16M | 800.5M | 1.7B | 1.68B | 1.55B |
Cash and Equivalents | 6.42M | 70.2M | 51.86M | 14.11M | 31.5M |
Total Non-Current Assets | 265.76M | 221.34M | 1.63B | 1.82B | 2B |
Total Liabilities | 472.69M | 1.05B | 693.16M | 681.11M | 1.06B |
Total Current Liabilities | 262.57M | 363.83M | 343.01M | 371.11M | 335.93M |
Total Non-Current Liabilities | 414.21M | 1.31B | 631.01M | 510M | 1.22B |
Total Equity | 265.76M | 221.34M | 1.63B | 1.82B | 2B |
Common Equity | 100.64M | 100.64M | 1.32B | 1.32B | 1.32B |
Retained Earnings | 0 | 84.64M | 0 | 0 | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.